The AMBP Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal cell population derived from A-549 human lung adenocarcinoma cells, featuring targeted disruption of the AMBP gene. This loss-of-function model enables studies on the AMBP precursor and its cleavage products, alpha-1-microglobulin (A1M) and bikunin, in an epithelial cancer context. The polyclonal format preserves population heterogeneity, allowing robust functional analyses without clonal selection biases.
A-549 cells serve as a well-established model for lung adenocarcinoma and respiratory epithelium research. Their epithelial morphology and consistent signaling characteristics make them suitable for investigating tumor cell-intrinsic processes, protease networks, and extracellular matrix (ECM) interactions relevant to cancer progression and therapeutic responses.
AMBP encodes a precursor processed into A1M and bikunin. A1M scavenges heme and radicals, while bikunin inhibits serine proteases such as plasmin, neutrophil elastase, and trypsin. Bikunin forms complexes with inter-alpha-trypsin inhibitor (ITI) heavy chains and hyaluronan, modulating ECM stability and inflammation. The gene is regulated by IL-6, TNF-??, glucocorticoids, and HNF4A. Bikunin-dependent protease inhibition can attenuate TGF-?? signaling, linking AMBP to fibrotic and migratory pathways. A1M contributes to antioxidant defense, and the bikunin?Chyaluronan?CITI network influences acute phase responses and tissue remodeling.
In A-549 cells, AMBP knockout ablates A1M-mediated antioxidant function and bikunin-dependent protease regulation, potentially increasing oxidative stress and disrupting ECM dynamics. Loss of plasmin and neutrophil elastase control may enhance matrix degradation and alter cell invasion and migration. Reduced hyaluronan complex formation could also impair inflammatory signaling and stromal crosstalk, impacting the tumor microenvironment. This model is thus valuable for dissecting AMBP??s role in cancer-associated inflammation, ECM remodeling, and metastasis.
This polyclonal knockout product supports research into serine protease inhibition, hyaluronan biology, and inflammatory signaling in lung adenocarcinoma. Assays such as Western blotting, RT-qPCR, protease activity measurements, hyaluronan binding, cell migration/invasion assays, IL-6 secretion profiling, heme-binding assays, and RNA-seq transcriptomics are well suited. The cells enable detailed mechanistic studies relevant to cancer biology, fibrosis, and inflammatory disorders. For further information or orders, please contact Ascent Research.
